Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 02, 2026
TickeronGET DAILY SIGNALS
Installed Building Products (IBP) +14% Rally Over 30 Days Backed by Analyst Support and Liquidity Move

Installed Building Products (IBP) +14% Rally Over 30 Days Backed by Analyst Support and Liquidity Move

Key Takeaways

  • Installed Building Products (IBP) shares climbed roughly 14% over the trailing 30 days, rising from about $193.00 to near $220.53.
  • The rally marked a sharp rebound from a multi-month low near $176 set in mid-October, as sentiment around the homebuilding supply chain improved.
  • Fresh analyst coverage and maintained Buy ratings, including new coverage at Bank of America and a Buy reiteration at Goldman Sachs, supported the move.
  • A $250 million add-on to the company's Term Loan B facility, closed in late October, reinforced balance-sheet and liquidity flexibility.
  • Over the trailing quarter, the stock remains modestly lower, highlighting that the recent gain is a recovery within a broader pullback.

Installed Building Products (IBP) Business Snapshot and Industry Role

Installed Building Products, Inc. is one of the largest installers of new residential insulation in the United States and a diversified installer of complementary building products, including waterproofing, fire-stopping, fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, and mirrors. The company serves single-family and multi-family residential builders as well as commercial customers, managing the full installation process from material procurement through job-site delivery and installation.

IBP operates a national network of more than 250 branch locations across all 48 continental states and the District of Columbia. Its scale, acquisition-driven growth strategy, and diversified product mix position it as a key supplier to the residential construction industry, which is why investors closely track its results as a barometer for housing demand. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

IBP Stock Price Moves: 30-Day Advance Versus Quarterly View

Over the trailing 30 days, IBP shares advanced approximately 14%, moving from a close near $193.00 to roughly $220.53. The gain represents a notable reversal after the stock traded near its 52-week low in mid-October.

The picture over the trailing quarter is more mixed. From a level near $228 in early August, the stock is still down roughly 3% to 4%, having fallen sharply into mid-October before the recent rebound. This means the 30-day rally has recaptured most, but not all, of the ground lost during the prior months.

Factors Behind the Recent 30-Day Advance

The recent advance was supported by a combination of analyst activity, corporate financial moves, and improving sector sentiment. In early October, Goldman Sachs maintained a Buy rating on the stock, and later in the month Stifel also reaffirmed its Buy rating, while Bank of America initiated coverage with a Buy in late October. Melius Research initiated coverage with a Hold rating in early October. These actions, alongside the stock's depressed valuation following months of declines, helped draw renewed buyer interest. From what I see, the timing of these updates added meaningful support.

The company also announced plans in mid-October to increase its existing Term Loan B facility by $250 million, and closed the transaction in late October, raising total outstanding principal to roughly $740 million with unchanged terms and a 2031 maturity. The move was framed as reinforcing financial flexibility for general corporate purposes. Separately, IBP scheduled its third-quarter 2026 earnings release, which added a forward-looking catalyst as investors positioned ahead of the report.

Broader Quarterly Pressures and Recovery Signals

Over the broader quarter, IBP faced pressure tied to softer residential construction conditions and cautious commentary around housing demand. The company's second-quarter 2026 results, reported in early August, showed record net revenue of $777.8 million, up 2.3% year over year, while installation revenue declined 0.7%. The mixed growth profile, combined with concerns about housing affordability and new construction activity, contributed to a selloff through September and into October.

Several analysts lowered price targets during the period, reflecting a more conservative near-term outlook, while corporate insiders recorded net selling activity. The late-October rebound, however, suggests some investors began to view the valuation as attractive relative to the company's longer-term positioning in residential construction. One thing that stands out is how quickly sentiment can shift on valuation resets.

Key Areas to Monitor Going Forward

The most immediate catalyst for IBP is its upcoming third-quarter earnings report, where investors will focus on installation revenue trends, margin performance, and management's outlook for residential construction demand. Guidance updates on new home starts, repair and remodel activity, and pricing will be closely watched.

Beyond earnings, key factors include mortgage rates and housing affordability, which influence new residential construction activity; analyst estimate revisions and price targets; and any further capital-allocation developments, including acquisitions, buybacks, and dividends. Macroeconomic conditions affecting homebuilders and the broader building products supply chain will also remain important to IBP's trajectory. I’m watching this closely as housing data continues to evolve.

Using Tickeron AI Tools in My Research Process

In reviewing stocks like this, I often turn to Tickeron’s AI Daily Buy/Sell Signals to cross-check momentum and pattern data alongside traditional analysis. The platform’s AI Trading Bots section also provides a useful way to see how automated strategies are performing across similar names, helping me compare approaches without overcomplicating the process. It keeps the research grounded while adding a systematic perspective.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IBP

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


IBP in upward trend: price rose above 50-day moving average on October 29, 2026

IBP moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 39 of 45 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IBP's RSI Oscillator exited the oversold zone, 25 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on IBP as a result. In 58 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for IBP just turned positive on October 08, 2026. Looking at past instances where IBP's MACD turned positive, the stock continued to rise in 39 of 48 cases over the following month. The odds of a continued upward trend are 81%.

Following a +6.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBP advanced for three days, in 229 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

IBP broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IBP entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 27 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 56 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. IBP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: IBP's P/B Ratio (8.867) is very high in comparison to the industry average of (1.826). P/E Ratio (22.892) is within average values for comparable stocks, (9.881). Projected Growth (PEG Ratio) (0.900) is also within normal values, averaging (1.217). Dividend Yield (0.007) settles around the average of (0.019) among similar stocks. P/S Ratio (1.816) is also within normal values, averaging (24.205).

Notable companies

The most notable companies in this group are DR Horton (NYSE:DHI), Pultegroup (NYSE:PHM), Lennar Corp (NYSE:LEN), KB Home (NYSE:KBH).

Industry description

Homebuilding includes companies residential home construction companies, renovators and repair firms. The companies may be building single-family or multifamily homes, condominiums or mobile homes. Over the five years to 2019, the Home Builders industry is estimated to have grown at an annualized rate of 2.5% to reach $89.4 billion, (including expected growth of 2.6% in 2019), according to a study by IbisWorld. After having suffered one of its worst crises a decade ago during the last macroeconomic recession–which had much of its origins in U.S. real estate – the homebuilding industry has been recovering steadily so far. Higher disposable incomes and improving economic activity have bolstered consumers’ purchases of homes. While revenue of the Home Builders industry remains well below its prerecession high, demand growth estimates show promise.

Market Cap

The average market capitalization across the Homebuilding Industry is 7.77B. The market cap for tickers in the group ranges from 12.75K to 40.84B. DHI holds the highest valuation in this group at 40.84B. The lowest valued company is BDCC at 12.75K.

High and low price notable news

The average weekly price growth across all stocks in the Homebuilding Industry was 6%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 5%. CVCO experienced the highest price growth at 25%, while BXBL experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Homebuilding Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was 55%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 32
Price Growth Rating: 58
SMR Rating: 71
Profit Risk Rating: 68
Seasonality Score: 56 (-100 ... +100)
View a ticker or compare two or three
IBP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of residential insulation installer

Industry Homebuilding

Industry
Building Products
Address
495 South High Street
Phone
+1 614 221-3399
Employees
10400
Web
https://www.installedbuildingproducts.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
AstraZeneca reported Q1 2026 total revenue of $15.3 billion, up 8% at constant exchange rates (CER, adjusting for currency fluctuations), beating consensus estimates around $14.8 billion. Core earnings per share (EPS) rose 5% to $2.58 at CER, amid a 12% increase in core operating profit.
Consensus estimates call for Q3 FY2026 revenue of approximately $3.37 billion, in line with the company's guidance midpoint of $3.35 billion. Non-GAAP earnings per share (EPS) expected at $9.16, edging above the guided midpoint of $9.08.
Installed Building Products (IBP) +14% Rally Over 30 Days Backed by Analyst Support and Liquidity Move